Harrow, Inc. Business Acquisition, Pro Forma Revenue
Harrow, Inc. (HROW) reported Business Acquisition, Pro Forma Revenue of $1.56 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-13.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2015-11-12
- Harrow, Inc. business acquisition, pro forma revenue for the quarter ending 2015-03-31 was $1.56M, a 2.36% increase year-over-year.
- Harrow, Inc. business acquisition, pro forma revenue for the quarter ending 2014-12-31 was -$3.57M, a 609.74% decline year-over-year.
- Harrow, Inc. business acquisition, pro forma revenue for the quarter ending 2014-09-30 was $1.85M, a 161.39% increase year-over-year.
- Harrow, Inc. business acquisition, pro forma revenue for the quarter ending 2014-06-30 was $1.72M, a 131.22% increase year-over-year.
- Harrow, Inc. business acquisition, pro forma revenue for fiscal 2014 was $2.28M, a 20.37% decline from fiscal 2013.
- Harrow, Inc. business acquisition, pro forma revenue for fiscal 2013 was $2.87M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 3 month as first filed | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 6 month as first filed | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 9 month as first filed | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|---|---|---|
| 2015-03-31 | $1.56M 10-Q · filed 2015-05-13 | -$2.00M derived: sum of 2 quarters · filed 2015-05-13 | -$150.32K derived: sum of 3 quarters · filed 2015-11-12 | $1.57M derived: sum of 4 quarters · filed 2015-11-12 | |||
| 2014-12-31 | -$3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$1.71M derived: sum of 2 quarters · filed 2015-11-12 | $7.68K derived: sum of 3 quarters · filed 2015-11-12 | $2.28M 10-K · filed 2015-03-12 | |||
| 2014-09-30 | $1.85M 10-Q · filed 2015-11-12 | $441.03K 10-Q · filed 2014-11-12 | $3.57M derived: sum of 2 quarters · filed 2015-11-12 | $5.85M 10-Q · filed 2015-11-12 | $1.73M 10-Q · filed 2014-11-12 | $5.80M derived: sum of 4 quarters · filed 2015-11-12 | |
| 2014-06-30 | $1.72M 10-Q · filed 2015-08-12 | $667.70K 10-Q · filed 2014-08-13 | $3.25M 10-Q · filed 2015-08-12 | $1.29M 10-Q · filed 2014-08-13 | $3.95M derived: sum of 3 quarters · filed 2015-08-12 | $4.66M derived: sum of 4 quarters · filed 2015-08-12 | |
| 2014-03-31 | $1.53M 10-Q · filed 2015-05-13 | $2.23M derived: sum of 2 quarters · filed 2015-05-13 | $2.94M derived: sum of 3 quarters · filed 2015-05-13 | $3.68M derived: sum of 4 quarters · filed 2015-05-13 | |||
| 2013-12-31 | $699.63K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $1.41M derived: sum of 2 quarters · filed 2015-03-12 | $2.15M derived: sum of 3 quarters · filed 2015-03-12 | $2.87M 10-K · filed 2015-03-12 | |||
| 2013-09-30 | $708.89K 10-Q · filed 2014-11-12 | $1.45M derived: sum of 2 quarters · filed 2014-11-12 | $2.17M 10-Q · filed 2014-11-12 | ||||
| 2013-06-30 | $744.30K 10-Q · filed 2014-08-13 | $1.45M 10-Q · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |